Skip to main content
Premium Trial:

Request an Annual Quote

Oh, You Do It

This post has been changed due to an update to the Technology Review article.

Technology Review focuses its attention on RainDance Technologies' droplet-based microfluidics system, saying it "can be adapted to perform a number of chemical analyses." The company itself, though, is not developing its own genetic diagnostics, Tech Review says, but is selling its technology to labs that do. Emory's Madhuri Hegde is using the technology to develop a test for an X-linked form of mental retardation that looks at 93 different genes. "I think [the RainDance technology] holds lots of promise in a clinical setting," Hegde says, though she notes that it is expensive.

The Scan

mRNA-Based Vaccine on the Way in China

China may soon have its own mRNA-based vaccine, according to Nature News.

Arranged Killing, Fraud Alleged by Prosecutors

The Wall Street Journal reports that prosecutors allege that the co-founder of a biotech arranged to have a business associate who threatened to expose him as a fraud killed.

Whirlwind Decade of CRISPR

The New York Times looks back at the 10 years since the University of California, Berkeley's Jennifer Doudna and her colleagues published their CRISPR paper.

PNAS Papers on Blue Cone Monochromacy Structural Variants, HIV-1 Mutant, T-ALL

In PNAS this week: structural variants linked to blue cone monochromacy, HIV-1 variants affecting the matrix protein p17, and more.